Intercell
Vienna
About Intercell
Intercell AG, a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious diseases. It discovers and develops antigens and adjuvants, which are derived from its proprietary technology platforms. The company was founded in 1998 and is headquartered in Vienna, Austria.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Total funding: $88.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2007)
- Ticker: vie:ICLL
- Website: intercell.com
- Phone: +43 0120-620-800
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/intercell-771094 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.